Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 23, Pages e2019740118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-06-02
DOI
10.1073/pnas.2019740118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors
- (2020) Patrick D. Bhola et al. Science Signaling
- The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes
- (2019) Margot E. Bowen et al. DEVELOPMENTAL CELL
- α-Ketoglutarate links p53 to cell fate during tumour suppression
- (2019) John P. Morris et al. NATURE
- iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry
- (2016) Jeremy Ryan et al. BIOLOGICAL CHEMISTRY
- Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
- (2016) J Le Pen et al. Cell Death & Disease
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Rapid modelling of cooperating genetic events in cancer through somatic genome editing
- (2014) Francisco J. Sánchez-Rivera et al. NATURE
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- High Mitochondrial Priming Sensitizes hESCs to DNA-Damage-Induced Apoptosis
- (2013) Julia C. Liu et al. Cell Stem Cell
- BH3 profiling in whole cells by fluorimeter or FACS
- (2013) Jeremy Ryan et al. METHODS
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Defining principles of combination drug mechanisms of action
- (2012) J. R. Pritchard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Regulation of tissue- and stimulus-specific cell fate decisions by p53 in vivo
- (2010) James G Jackson et al. JOURNAL OF PATHOLOGY
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Stage-specific sensitivity to p53 restoration during lung cancer progression
- (2010) David M. Feldser et al. NATURE
- A mammalian functional-genetic approach to characterizing cancer therapeutics
- (2010) Hai Jiang et al. Nature Chemical Biology
- p53 Research: The Past Thirty Years and the Next Thirty Years
- (2010) D. Lane et al. Cold Spring Harbor Perspectives in Biology
- Tied Up in Loops: Positive and Negative Autoregulation of p53
- (2009) X. Lu Cold Spring Harbor Perspectives in Biology
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started